Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small cell lung carcinoma in the elderly.

G H Clamon, M W Audeh, S Pinnick

    Journal of the American Geriatrics Society
    |May 1, 1982
    PubMed
    Summary

    Elderly patients over 70 with small cell lung cancer often have multiple health issues. Combination chemotherapy can still benefit these older individuals, improving survival outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    MDS and secondary AML: an evolutionary perspective.

    Cancer treatment and research·2001
    Same author

    Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2000
    Same author

    A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.

    Cancer·1998
    Same author

    A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer.

    Seminars in oncology·1997
    Same author

    Genetic predisposition testing for breast cancer.

    The cancer journal from Scientific American·1997

    Area of Science:

    • Oncology
    • Geriatric Medicine
    • Pulmonology

    Background:

    • Small cell lung cancer (SCLC) predominantly affects older adults.
    • Elderly patients frequently present with significant comorbidities, complicating treatment decisions.
    • The impact of SCLC treatment on this specific demographic requires further investigation.

    Purpose of the Study:

    • To evaluate the outcomes of elderly patients (over 70) diagnosed with small cell lung cancer.
    • To assess the feasibility and efficacy of combination chemotherapy in this population.
    • To analyze the influence of comorbidities on treatment response and survival.

    Main Methods:

    • Retrospective analysis of 24 patients aged 70 and above with SCLC.
    • Review of patient demographics, comorbidities, treatment regimens, and survival data.
    • Statistical analysis to determine median survival and one-year survival rates.

    Main Results:

    • 92% of patients had concurrent medical disorders, including 58% with cardiac disease and 25% with a second malignancy.
    • The median survival for 20 treated patients was 10 months.
    • The one-year survival rate was 30% for the treated cohort.

    Conclusions:

    • Elderly patients with SCLC, even those with multiple comorbidities, can achieve survival benefits from combination chemotherapy.
    • Multidisciplinary care and tailored treatment strategies are crucial for managing SCLC in the elderly.
    • Further prospective studies are warranted to optimize chemotherapy regimens for this vulnerable patient group.

    Related Experiment Videos